Left ventricular myofilament dysfunction in rat experimental hypertrophy and congestive heart failure
about
Integration of troponin I phosphorylation with cardiac regulatory networksWhy does troponin I have so many phosphorylation sites? Fact and fancyCardiac thin filament regulationSexually dimorphic myofilament function and cardiac troponin I phosphospecies distribution in hypertrophic cardiomyopathy miceThin filament incorporation of an engineered cardiac troponin C variant (L48Q) enhances contractility in intact cardiomyocytes from healthy and infarcted hearts.Regulation of fibre contraction in a rat model of myocardial ischemia.Reduced force production during low blood flow to the heart correlates with altered troponin I phosphorylationPhosphoprotein abundance changes in hypertensive cardiac remodeling.Myofilament dysfunction contributes to impaired myocardial contraction in the infarct border zoneNovel function of cardiac protein kinase D1 as a dynamic regulator of Ca2+ sensitivity of contractionMyofilament calcium sensitization delays decompensated hypertrophy differently between the sexes following myocardial infarctionDiastolic myofilament dysfunction in the failing human heart.Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction.Interventricular differences in myofilament function in experimental congestive heart failure.Cell-to-cell variability in troponin I phosphorylation in a porcine model of pacing-induced heart failure.In vivo phosphorylation site mapping in mouse cardiac troponin I by high resolution top-down electron capture dissociation mass spectrometry: Ser22/23 are the only sites basally phosphorylated.ACE inhibition prevents diastolic Ca2+ overload and loss of myofilament Ca2+ sensitivity after myocardial infarction.Myosin cross-bridge dynamics in patients with hypertension and concentric left ventricular remodeling.Rate-dependent force, intracellular calcium, and action potential voltage alternans are modulated by sarcomere length and heart failure induced-remodeling of thin filament regulation in human heart failure: A myocyte modeling study.Myocardial infarction in mice alters sarcomeric function via post-translational protein modification.Pacemaker-induced transient asynchrony suppresses heart failure progressionSex dimorphisms of crossbridge cycling kinetics in transgenic hypertrophic cardiomyopathy miceThe role of Akt/GSK-3beta signaling in familial hypertrophic cardiomyopathy.Cell therapy enhances function of remote non-infarcted myocardium.Impairment of diastolic function by lack of frequency-dependent myofilament desensitization rabbit right ventricular hypertrophy.Impact of actin glutathionylation on the actomyosin-S1 ATPase.Differential effects of phosphorylation of regions of troponin I in modifying cooperative activation of cardiac thin filaments.CaMKII-dependent myofilament Ca2+ desensitization contributes to the frequency-dependent acceleration of relaxation.Detrimental effect of combined exercise training and eNOS overexpression on cardiac function after myocardial infarction.Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction.Development of contractile dysfunction in rat heart failure: hierarchy of cellular events.
P2860
Q26852120-BC4D8529-05CB-4D8E-8F33-3379C623C6D6Q28274412-1510DAAB-0CC1-449C-B0DA-24498B82396DQ28276960-944A20EB-6A3C-4CFF-9193-01382C9C1799Q30539357-92A848EF-3666-45A5-8248-D61FD53CA611Q30582828-CF692E97-7108-487C-8EE2-F4EE3DBB3991Q33538026-DA09710A-9F5D-476A-9F65-D304236C70B5Q33641335-91813079-BC8D-4157-84BB-1F55AEC5BD70Q34289975-86BFFB39-9E14-4DB3-BBFD-D25C95DC81EAQ34356175-137C970C-EF3E-4B84-BA09-CDDA53B361B7Q34438891-84281970-FAF2-4DAF-AB76-E04DE937E498Q34598629-E83C05A6-B9D4-46D4-994D-F10B1E7C5B9CQ35042592-7CDFC919-0DFA-4598-B21C-D5BF9D08491AQ35634229-54564512-B856-4D2F-ADCF-57274E35CAF9Q35636210-D3F05673-A28F-47DB-AF17-D4FFBDEE1BB5Q35898464-6315848B-1697-491A-B5D7-E25C3248D731Q35925687-8C6E54E9-4123-4100-8E6F-3DEF322D9B4BQ36320507-ED44EBBA-1E92-4ABC-84EE-4065F62ABD85Q36421971-4AEBB072-8C77-48BE-B62E-2C4CB2158F99Q36730722-0152EFF9-C342-411B-98EA-6659744CE167Q36860519-D4E0067A-D3E5-4552-BF1C-8EF2505B4C89Q36874396-E814160B-42CE-4914-A124-2D28E688F775Q37139640-A91A4C0C-55B2-405E-BD17-BA89EC29ACB4Q37239549-7B264FF3-C941-4A76-ACAB-2174FE386B09Q37390252-38573011-18BD-4735-9F9D-848EC1313909Q37402315-00C6126F-8AE2-4CBF-8293-D0EA176B14C1Q41861657-D5EEBDBA-8506-4622-AFEA-D9CCD70DCEE7Q42585795-1EA1B71E-5B39-4ECC-947D-895BDFBAD0B8Q43151233-EC5912CD-58B3-46A5-9E64-ED33AE54E35CQ46087965-B465327C-9B89-42BB-973A-1C8530F6D18EQ48772970-2FFABD4B-7FB0-41B3-A57B-3DA9B76A68CAQ51919754-B5BCA9C9-77B8-4B34-B70F-DFF33ADDFED3
P2860
Left ventricular myofilament dysfunction in rat experimental hypertrophy and congestive heart failure
description
article
@en
im Juni 2006 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2006
@uk
name
Left ventricular myofilament d ...... y and congestive heart failure
@en
Left ventricular myofilament d ...... y and congestive heart failure
@nl
type
label
Left ventricular myofilament d ...... y and congestive heart failure
@en
Left ventricular myofilament d ...... y and congestive heart failure
@nl
prefLabel
Left ventricular myofilament d ...... y and congestive heart failure
@en
Left ventricular myofilament d ...... y and congestive heart failure
@nl
P2093
P2860
P1476
Left ventricular myofilament d ...... y and congestive heart failure
@en
P2093
Dalia Urboniene
David L Geenen
Marius P Sumandea
Milana Yuzhakova
Pieter P de Tombe
R John Solaro
Rashad J Belin
Stuart H Ruch
Tomoyoshi Kobayashi
Veronica L Rundell
P2860
P304
P356
10.1152/AJPHEART.00541.2006
P50
P577
2006-06-30T00:00:00Z